IL6 and COVID-19: Rodrigues TS et al. studied moderate and severe COVID-19 patients and found that inflammasome-derived products such as caspase-1 and IL-18 in the sera are correlated with markers of COVID-19 severity, including IL-6 and lactate dehydrogenase (LDH).